Bone morphogenetic proteins and their antagonists
- PMID: 17029022
- DOI: 10.1007/s11154-006-9000-6
Bone morphogenetic proteins and their antagonists
Abstract
Skeletal homeostasis is determined by systemic hormones and local factors. Bone morphogenetic proteins (BMPs) are unique because they induce the commitment of mesenchymal cells toward cells of the osteoblastic lineage and also enhance the differentiated function of the osteoblast. BMP activities in bone are mediated through binding to specific cell surface receptors and through interactions with other growth factors. BMPs are required for skeletal development and maintenance of adult bone homeostasis, and play a role in fracture healing. BMPs signal by activating the mothers against decapentaplegic (Smad) and mitogen activated protein kinase (MAPK) pathways, and their actions are tempered by intracellular and extracellular proteins. The BMP antagonists block BMP signal transduction at multiple levels including pseudoreceptor, inhibitory intracellular binding proteins, and factors that induce BMP ubiquitination. A large number of extracellular proteins that bind BMPs and prevent their binding to signaling receptors have emerged. The extracellular antagonists are differentially expressed in cartilage and bone tissue and exhibit BMP antagonistic as well as additional activities. Both intracellular and extracellular antagonists are regulated by BMPs, indicating the existence of local feedback mechanisms to modulate BMP cellular activities.
Similar articles
-
Bone morphogenetic proteins, their antagonists, and the skeleton.Endocr Rev. 2003 Apr;24(2):218-35. doi: 10.1210/er.2002-0023. Endocr Rev. 2003. PMID: 12700180 Review.
-
Potential drug targets within bone morphogenetic protein signaling pathways.Curr Opin Pharmacol. 2007 Jun;7(3):325-33. doi: 10.1016/j.coph.2007.01.003. Epub 2007 May 1. Curr Opin Pharmacol. 2007. PMID: 17475557 Review.
-
Bmp modulators in kidney disease.Discov Med. 2012 Jan;13(68):57-63. Discov Med. 2012. PMID: 22284784 Review.
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
-
Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN.Arthritis Res. 2001;3(1):1-5. doi: 10.1186/ar133. Epub 2000 Nov 14. Arthritis Res. 2001. PMID: 11178121 Free PMC article. Review.
Cited by
-
Notch and the skeleton.Mol Cell Biol. 2010 Feb;30(4):886-96. doi: 10.1128/MCB.01285-09. Epub 2009 Dec 7. Mol Cell Biol. 2010. PMID: 19995916 Free PMC article. Review.
-
BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment.BMC Cancer. 2013 Sep 22;13:429. doi: 10.1186/1471-2407-13-429. BMC Cancer. 2013. PMID: 24053318 Free PMC article.
-
Bone morphogenetic protein 2 inhibits growth differentiation factor 8-induced cell signaling via upregulation of gremlin2 expression in human granulosa-lutein cells.Reprod Biol Endocrinol. 2021 Nov 27;19(1):173. doi: 10.1186/s12958-021-00854-6. Reprod Biol Endocrinol. 2021. PMID: 34838049 Free PMC article.
-
Biology of BMP signalling and cancer.Clin Transl Oncol. 2009 Mar;11(3):126-37. doi: 10.1007/s12094-009-0328-8. Clin Transl Oncol. 2009. PMID: 19293049 Review.
-
Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation.Mol Syndromol. 2014 Aug;5(5):201-11. doi: 10.1159/000365770. Epub 2014 Aug 7. Mol Syndromol. 2014. PMID: 25337067 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources